Home › Glioblastoma › Georgia › Atlanta
Studi clinici su Glioblastoma a Atlanta, GA
11 studi su Glioblastoma cercano partecipanti presso sedi a Atlanta e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
In reclutamentoFase 3
- Winship Cancer Institute at Emory University, Atlanta
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
In reclutamentoFase 3
- Emory Winship Cancer Institute, Atlanta
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
In reclutamentoFase 1/2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
In reclutamentoFase 2
- Piedmont Oncology Research, Atlanta
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
In reclutamentoFase 1/2
- Children's Healthcare of Atlanta - Egleston Hospital, Atlanta
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
In reclutamentoFase 1
- Emory University Hospital/Winship Cancer Institute, Atlanta
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
In reclutamentoFase 3
- Emory University, Atlanta
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
In reclutamentoFase 2
- Emory University Hospital/Winship Cancer Institute, Atlanta
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
In reclutamentoFase 1
- Emory University, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Atlanta
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
In reclutamentoFase 1/2
- Emory University Hospital/Winship Cancer Institute, Atlanta
Studi su Glioblastoma in altre città
- New York City, NY30 studi
- Boston, MA28 studi
- Houston, TX26 studi
- Los Angeles, CA24 studi
- Durham, NC20 studi
- San Francisco, CA17 studi
- Chicago, IL15 studi
- Washington, DC15 studi
- Columbus, OH14 studi
- Miami, FL14 studi
- Rochester, MN13 studi
- Jacksonville, FL13 studi
Altri studi a Atlanta
- Cancro (tutti i tipi)49 studi
- Cancro del polmone non a piccole cellule47 studi
- Mieloma multiplo42 studi
- Cancro al seno41 studi
- Cancro alla prostata33 studi
- Leucemia mieloide acuta31 studi
- Cancro ovarico29 studi
- Cancro colorettale29 studi
- Cancro ai polmoni29 studi
- Cancro metastatico28 studi
- Disturbo depressivo maggiore25 studi
- Insufficienza cardiaca25 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.